Patents by Inventor Robson A. S. Dos Santos

Robson A. S. Dos Santos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEMS FOR DELIVERY AND RELEASE OF ANGIOTENSIN-(1-7)
    Publication number: 20100158995
    Abstract: The prior art lacks a formulation, application or product of D-Ala7-Angiotensin-(1-7) (A-779) and analogues and derivatives, D-Pro7-Angiotensin-(1-7) and analogues or derivatives or of Ang-(1-7) analogues or derivatives using cyclodextrins, liposomes, biodegradable polymers and its derivatives for the study or treatment of arterial hypertension and other cardiovascular diseases, wounds, burns, arrhythmia, tumors, diabetes mellitus, sperm mobility, nephropathy, gastrointestinal and gynecological disorders, angiogenesis, angioplatsy, alopecia and blood diseases in warm blooded animals, or as ligands for de G-protein-coupled receptor MAS. This characterizes the present invention as a more effective option for the study and treatment of pathologies associated or not to this receptor.
    Type: Application
    Filed: March 1, 2010
    Publication date: June 24, 2010
    Applicant: Universidade Federal De Minas Gerais-UFMG
    Inventors: Rubén D.S. MILLÁN, Robson A.S. Dos Santos, Fréderic J.G. Frezad, Ana P. Nadu
  • Systems for delivery and release of angiotensin-(1-7)
    Patent number: 7723304
    Abstract: The prior art lacks a formulation, application or product of D-Ala7-Angiotensin-(1-7) (A-779) and analogues and derivatives, D-Pro7-Angiotensin-(1-7) and analogues or derivatives or of Ang-(1-7) analogues or derivatives using cyclodextrins, liposomes, biodegradable polymers and its derivatives for the study or treatment of arterial hypertension and other cardiovascular diseases, wounds, burns, arrhythmia, tumors, diabetes mellitus, sperm mobility, nephropathy, gastrointestinal and gynaecologicalgynecological disorders, angiogenesis, angioplatsy, alopecia and blood diseases in warm blooded animals, or as ligands for de G-protein-coupled receptor MAS. This characterizes the present invention as a more effective option for the study and treatment of pathologies associated or not to this receptor.
    Type: Grant
    Filed: November 5, 2002
    Date of Patent: May 25, 2010
    Assignee: Universidade Federal De Minas Gerais—UFMG
    Inventors: Rubén D. S. Millan, Robson A. S. Dos Santos, Fréderic J. G. Frezad, Ana P. Nadu